BASECURE THERAPEUTICS
DEAD

Serial Number

97770124

Owner

BASECURE THERAPEUTICS INC.

Attorney

Christina D. Frangiosa

Filing Date

Jan 27, 2023

Add to watchlist:

No watchlists yet
View on USPTO

BASECURE THERAPEUTICS Trademark

Serial Number: 97770124

BASECURE THERAPEUTICS is a trademark filed by BASECURE THERAPEUTICS INC. on January 27, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

BASECURE THERAPEUTICS INC.

Sertus Chmbrs, Gov's Sq, Ste 5-204
Grand Cayman KY1-1104 , KY

Entity Type: 03

Trademark Details

Filing Date

January 27, 2023

Registration Date

Not Registered

Goods & Services

Medicines for human purposes; chemico-pharmaceutical preparations; drugs for medical purposes; pharmaceutical preparations for suppressing tumors; Anti-cancer preparations; pharmaceutical preparations for the prevention and treatment of cancer; sarkomycin preparations; biological preparations for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; Pharmaceuticals for the treatment of cancer; cardiovascular pharmaceuticals; pharmaceutical preparations for the treatment of hypertension; pharmaceutical preparations for treating cardiovascular diseases; cardiovascular agents for medical purposes; vasopressin; Vasoconstrictors; pharmaceutical preparations for the treatment of diabetes; Anti-diabetic pharmaceuticals; pharmaceutical preparations and substances for the treatment of metabolic diseases and disorders; pharmaceutical preparations for treating hypoglycemia; lipotropic factor preparations; pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; pharmaceutical preparations for the central nervous system; pharmaceutical preparations for the peripheral nervous system; autonomic drugs for medical purposes; nervines; Pharmaceutical products for treating respiratory diseases; Pharmaceutical preparations to be inhaled for the prevention and treatment of respiratory diseases and disorders; Pharmaceutical preparations for the treatment of autoimmune diseases; pharmaceutical preparations for the treatment of immune system related diseases and disorders; antivirals; Pharmaceutical preparations for the treatment of chronic liver diseases

Scientific laboratory services; scientific research; scientific research for medical purposes in the field of cancerous diseases; scientific surveys for medical purpose; research and development of new products for others; pharmaceutical research and development; drug development; Conducting early evaluations in the field of new pharmaceuticals; development of pharmaceutical preparations and medicines; medical research; clinical trials; structural and functional analysis of genomes; biomedical research; Research and development services in the field of antibodies; Medical research in the field of epidemiology; research and development services relating to vaccines

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Mar 4, 2024 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Mar 4, 2024 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 2, 2023 GNRN
NON-FINAL ACTION E-MAILED
Nov 2, 2023 GNRT
NON-FINAL ACTION WRITTEN
Nov 2, 2023 CNRT
ASSIGNED TO EXAMINER
Oct 26, 2023 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Feb 16, 2023 MDSM
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 15, 2023 NWOS
NEW APPLICATION ENTERED
Jan 31, 2023 NWAP